CBOA
JAZZ icon

Commonwealth Bank of Australia’s Jazz Pharmaceuticals JAZZ Stock Holding History

Commonwealth Bank of Australia’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-775
Closed -$110K – 484
2019
Q2 		$110K Buy
775
+132
+21% +$17.7K ﹤0.01% 936
2019
Q1 		$91K Buy
643
+52
+9% +$6.78K ﹤0.01% 935
2018
Q4 		$72K Hold
591
– – ﹤0.01% 946
2018
Q3 		$98K Hold
591
– – ﹤0.01% 970
2018
Q2 		$101K Sell
591
-7
-1% -$1.14K ﹤0.01% 659
2018
Q1 		$90K Sell
598
-85
-12% -$12.5K ﹤0.01% 627
2017
Q4 		$90K Sell
683
-47
-6% -$6.52K ﹤0.01% 618
2017
Q3 		$106K Sell
730
-179
-20% -$27.1K ﹤0.01% 625
2017
Q2 		$140K Hold
909
– – ﹤0.01% 659
2017
Q1 		$132K Buy
909
+82
+10% +$10.7K ﹤0.01% 644
2016
Q4 		$90K Sell
827
-12
-1% -$1.34K ﹤0.01% 653
2016
Q3 		$101K Hold
839
– – ﹤0.01% 633
2016
Q2 		$119K Buy
839
+94
+13% +$13.9K ﹤0.01% 598
2016
Q1 		$97K Buy
745
+223
+43% +$27.8K ﹤0.01% 632
2015
Q4 		$73K Buy
522
+222
+74% +$30.8K ﹤0.01% 693
2015
Q3 		$40K Buy
300
+100
+50% +$17.2K ﹤0.01% 778
2015
Q2 		$35K Buy
200
+100
+100% +$18K ﹤0.01% 741
2015
Q1 		$17K Buy
+100
New +$17.2K ﹤0.01% 759
2014
Q2 		– Sell
-59,554
Closed -$8.26M – 921
2014
Q1 		$8.26M Sell
59,554
-9,323
-14% -$1.4M 0.05% 328
2013
Q4 		$8.72M Sell
68,877
-19,053
-22% -$1.97M 0.06% 301
2013
Q3 		$8.09M Buy
+87,930
New +$7.09M 0.06% 286

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Commonwealth Bank of Australia's JAZZ Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 775 shares — an estimated $110K sold.

Commonwealth Bank of Australia first reported a position in JAZZ in Q3 2013 and held it in 21 quarters. The position peaked at $8.72M in Q4 2013. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 775 Jazz Pharmaceuticals shares in Q3 2019, an estimated $110K.
  • Commonwealth Bank of Australia first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 21 quarters.
  • Commonwealth Bank of Australia's Jazz Pharmaceuticals position peaked at $8.72M in Q4 2013.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.